US FDA News: Quidel Recalls Lyra SARS-CoV-2 Assay (M120) Due to Risk of False Negative Results

Quidel is recalling the Lyra SARS-CoV-2 Assay (M120) due to a significant risk of false negative results for patients with high virus amounts
Read more: Quidel Recalls Lyra SARS-CoV-2 Assay (M120) Due to Risk of False Negative Results